Objectives: Digital technology breakthroughs, advances in computer vision technology and artificial intelligence are meant to improve access to dermatology care to acne patients. More than ever dermatologists / PCPs are needed to manage acne patients.
Introduction: While there are 2 billion persons on earth suffering from a skin conditions, 70% (or 1.4 billion) do not have access to dermatology care. Acne is #1 skin pathology and depending the country between 60% to 83% of patients are not seen by a dermatologist / PCP. This gap is both a threat for the profession and a great opportunity for new players to enter that market.
Materials / method: Daily market intelligence (lay press and professional sources) on the following domains: dermatology, skincare, aesthetics, innovation, access to care, misinformation, artificial intelligence and digital advances. All this being captured and shared on Twitter ( https://twitter.com/ducrest ) and LinkedIN (https://www.linkedin.com/in/dominique-du-crest-2982a/recent-activity/posts/ ).
Results: Greater access to acne care is a great opportunity for all parties. Numerous digital solutions aiming at bridging it are being launched but artificial intelligence can’t search for causes of what is observed (no explanatory power). Social media has also a great role to play. Recent NICE acne guidelines are demonstrating the complexity of acne management and how doctors should act in the long term.
Conclusion: Digital advances in technology and social media should not be seen as a threat to doctors. Although some solutions will be done without doctor supervision, more than ever dermatologists / PCPs are needed to manage acne patients.
Декларация COI
Получили ли вы финансовую поддержку для поисков этой ТЕМЫ?
Нет
Были ли вам предоставлены гонорары, выплаты или иная компенсация за вашу работу в этом исследовании?
Нет
Есть ли у Вас финансовые отношения с лицами, тесно конкурирующими с препаратами, изделиями или приборами, указанными в вашей презентации?
Нет
Вы владеете или подали заявку на какие-либо патенты по инструментам, лекарствам или материалам для вашего исследования?
Нет
Эта работа не была поддержана никаким прямым или не прямым финансированием. Находится под собственной ответственностью автора.